SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Fernandes Larry

(Last) (First) (Middle)
5 WESTBROOK CORPORATE CENTER

(Street)
WESTCHESTER IL 60154

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/01/2018
3. Issuer Name and Ticker or Trading Symbol
Ingredion Inc [ INGR ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Sr VP and Chief Commercial Off
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 12,938.4574(1)(2) D
Common Stock 4,587.9 I By 401(k) Plan
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Options (Right to Buy) (3) 02/07/2021 Common Stock 2,200 47.95 D
Employee Stock Options (Right to Buy) (4) 02/06/2022 Common Stock 3,000 55.95 D
Employee Stock Options (Right to Buy) (5) 02/04/2023 Common Stock 3,044 66.07 D
Employee Stock Options (Right to Buy) (6) 02/03/2024 Common Stock 6,746 59.58 D
Employee Stock Options (Right to Buy) (7) 02/02/2025 Common Stock 4,738 82.28 D
Employee Stock Options (Right to Buy) (8) 02/01/2026 Common Stock 4,700 99.96 D
Employee Stock Options (Right to Buy) (9) 02/06/2027 Common Stock 3,799 118.97 D
Employee Stock Options (Right to Buy) (10) 02/05/2028 Common Stock 5,005 130.3 D
Explanation of Responses:
1. Includes 4,762.3814 restricted stock units ("RSUs") issued under the Ingredion Incorporated Stock Incentive Plan. The RSUs may be settled only in shares of common stock (one share per RSU). 3,148.2323 RSUs will vest on January 1, 2019; 568.1407 RSUs will vest on February 2, 2019; 470.0084 RSUs will vest on February 7, 2020 and 576 RSUs will vest on February 6, 2021. In the event of termination of employment due to (a) death, (b) disability or (c) retirement on or after (i) age 65, (ii) age 62 with 5 years of service or (iii) age 55 with 10 years of service, the RSUs will vest on a pro-rata basis using the number of full months employed during the thirty-six month vesting period. Notwithstanding the foregoing, in the event of such retirement on or after February 6, 2019, the RSUs granted on February 6, 2018 will vest on February 6, 2021.
2. Includes RSUs acquired through deemed dividend reinvestment. RSUs acquired through deemed dividend reinvestment vest on the dates when the RSUs with respect to which they are deemed dividends vest.
3. The grant of options which included these options vested in three equal annual installments on February 8, 2012, 2013 and 2014.
4. These options vested in three equal annual installments on February 7, 2013, 2014 and 2015.
5. These options vested in three equal annual installments on February 5, 2014, 2015 and 2016.
6. These options vested in three equal annual installments on February 4, 2015, 2016 and 2017.
7. These options vested in three equal annual installments on February 3, 2016, 2017 and 2018.
8. Two thirds of these options vested in equal annual installments on February 2, 2017 and 2018, and the remaining one third of these options will vest on February 2, 2019.
9. One third of these options vested on February 7, 2018, and the remaining two thirds of these options will vest in equal annual installments on February 7, 2019 and 2020.
10. These options will vest in three equal annual installments on February 6, 2019, 2020 and 2021.
Remarks:
Exhibit List Exhibit 24-Power of Attorney
Christine M. Castellano, Attorney-in-Fact 03/12/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
 								EXHIBIT 24
POWER OF ATTORNEY


	Know all by these presents, that the undersigned hereby constitutes
and appoints each of Christine M. Castellano and John E. Lowe, signing
singly, the undersigned's true and lawful attorney-in-fact to:

(1) prepare, execute in the undersigned's name and on the undersigned's
behalf, and submit to the U.S. Securities and Exchange Commission (the
"SEC") a Form ID, including amendments thereto, and other documents
necessary or appropriate to obtain codes and passwords enabling the
undersigned to make electronic filings with the SEC of reports required
by Section 16(a) of the Securities Exchange Act of 1934 or any rule or
regulation of the SEC;

(2) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer and/or director of Ingredion Incorporated (the
"Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934 and the rules thereunder, and any other
forms or reports the undersigned may be required to file in connection
with the undersigned's ownership, acquisition, or disposition of
securities of the Company;

(3) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such
Form 3, 4, or 5, or other form or report, and timely file such form or
report with the SEC and any stock exchange or similar authority; and

(4) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of
benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such attorney-in
fact's discretion.

	The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing
whatsoever requisite, necessary, or proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all intents
and purposes as the undersigned might or could do if personally present,
with full power of substitution or revocation, hereby ratifying and
confirming all that such attorney-in-fact, or such attorney-in-fact's
substitute or substitutes, shall lawfully do or cause to be done by
virtue of this Power of Attorney and the rights and powers herein
granted.  The undersigned acknowledges that the foregoing attorneys-in-
fact, in serving in such capacity at the request of the undersigned, are
not assuming, nor is the Company assuming, any of the undersigned's
responsibilities to comply with Section 16 of the Securities Exchange
Act of 1934.

	This Power of Attorney shall remain in full force and effect
until the undersigned is no longer required to file Forms 3, 4, and 5
with respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the
undersigned in a signed writing delivered to the foregoing attorneys-
in-fact.

	IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 1 day of March, 2018.


					/s/Larry Fernandes
					Larry Fernandes